About: QUANTITATIVE MICROSAMPLING FOR BIOANALYTICAL APPLICATIONS RELATED TO THE SARS-CoV-2 PANDEMIC: USEFULNESS, BENEFITS AND PITFALLS

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: QUANTITATIVE MICROSAMPLING FOR BIOANALYTICAL APPLICATIONS RELATED TO THE SARS-CoV-2 PANDEMIC: USEFULNESS, BENEFITS AND PITFALLS Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	QUANTITATIVE MICROSAMPLING FOR BIOANALYTICAL APPLICATIONS RELATED TO THE SARS-CoV-2 PANDEMIC: USEFULNESS, BENEFITS AND PITFALLS
Creator	Mandrioli, Roberto Mercolini, Laura Protti, Michele
source	PMC
abstract	The multiple pathological effects of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and its total novelty, mean that currently a lot of diagnostic and therapeutic tools, established and tentative alike, are needed to treat patients in a timely, effective way. In order to make these tools more reliable, faster and more feasible, biological fluid microsampling techniques could provide many advantages. In this review, the most important microsampling techniques are considered (dried matrix spots, volumetric absorption microsampling, microfluidics and capillary microsampling, solid phase microextraction) and their respective advantages and disadvantages laid out. Moreover, currently available microsampling applications of interest for SARS-CoV-2 therapy are described, in order to make them as much widely known as possible, hopefully providing useful information to researchers and clinicians alike.
has issue date	2020-08-30(xsd:dateTime)
bibo:doi	10.1016/j.jpba.2020.113597
has license	no-cc
schema:url	https://doi.org/10.1016/j.jpba.2020.113597
resource representing a document's title	QUANTITATIVE MICROSAMPLING FOR BIOANALYTICAL APPLICATIONS RELATED TO THE SARS-CoV-2 PANDEMIC: USEFULNESS, BENEFITS AND PITFALLS
has PubMed Central identifier	PMC7456588
schema:publication	J Pharm Biomed Anal
resource representing a document's body	covid:PMC7456588#body_text
is schema:about of	named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'cellulose' named entity 'ritonavir' named entity 'malaria' named entity 'viral RNA' named entity 'room temperature' named entity 'urine' named entity 'anticoagulants' named entity 'infection' named entity 'qualitative tests' named entity 'sol-gel' named entity 'acute respiratory distress syndrome' named entity 'infection' named entity 'urine' named entity 'unfractionated heparin' named entity 'tamper-resistant' named entity 'gas chromatographic' named entity 'budesonide' named entity 'SPME' named entity 'Microfluidic' named entity 'SARS-CoV-2' named entity '7.5' named entity 'TDM' named entity 'bioanalytical' named entity 'venepuncture' named entity 'Lithium salts' named entity 'capillary' named entity 'tocilizumab' named entity 'analyte' named entity 'pharmacokinetic' named entity 'congenital diseases' named entity 'thromboembolic events' named entity 'antibodies' named entity 'ELF' named entity 'antivirals' named entity 'invasive procedures' named entity 'microfluidic' named entity 'SARS-CoV-2' named entity 'camostat' named entity 'exogenous' named entity 'desorbed' named entity 'acute phase' named entity 'bronchoscopic' named entity 'equilibrium' named entity 'plastic' named entity 'capillaries' named entity 'drug-drug interactions' named entity 'mass spectrometry' named entity 'biofluid' named entity 'SARS-CoV-2' named entity 'arbidol' named entity 'stainless steel' named entity 'thromboembolic events' named entity 'Cyclosporin' named entity 'saliva' named entity 'lopinavir' named entity 'plasma' named entity 'plasma' named entity 'hydroxychloroquine' named entity 'DIC' named entity 'protease inhibitor' named entity 'polymer' named entity 'respiratory tract' named entity 'infection' named entity 'respiratory tract' named entity 'biological fluid' named entity 'desorption' named entity '3.8' named entity 'corticosteroid' named entity 'point-of-care' named entity 'viscosity' named entity 'nucleic acids' named entity 'capillaries' named entity 'ribavirin' named entity 'corticosteroids' named entity 'SARS-CoV-2' named entity 'cytokine' named entity 'SPME' named entity 'immunological' named entity 'SPME' named entity 'polymers'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software